CHEST 2019

Study shows that in-hospital influenza vaccination may lower costs, risk for readmission or death

Use of home oxygen is associated with reduced physical function in patients with either COPD or idiopathic pulmonary fibrosis.

Trial stopped early due to futility with respect to primary end point and safety concerns

Patients with tobacco dependence and pulmonary embolism are likely to be readmitted to the hospital within 30 days of initial discharge due to pulmonary embolism.

Gefapixant has demonstrated efficacy in improving objective cough frequency and quality of life among individuals with chronic cough.

Combination therapy consisting of once-daily macitentan and tadalafil was associated with reductions in pulmonary vascular resistance in patients with pulmonary arterial hypertension.

Patients with acute exacerbation of COPD and acute MI who received invasive ventilation with high-concentration oxygen therapy experienced significant improvements in outcomes compared with patients on moderate-concentration oxygen therapy.

Twice-daily ensifentrine was associated with improvements in several symptoms of COPD, including breathlessness, chest symptoms, cough and sputum, and shortness of breath.

Clinical experts in pulmonary arterial hypertension (PAH) identified certain hemodynamic variables as predictive of patient survival that were different from variables found in major clinical trials.

Twice-daily selexipag was associated with improvements in 6-minute walk distance and potential maintenance or improvement in World Health Organization functional class in patients with pulmonary arterial hypertension.